Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous stromal vascular fraction injection for thumb carpometacarpal osteoarthritis
2024-515317-18-00Phase 2Authorised
- Sponsor
- Rouen University Hospital
- Start
- Oct 2023
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of autologous adipose-derived stromal vascular fraction in Rhizarthrosis, sponsored by Rouen University Hospital. Planned start Oct 2023; status: authorised.
02
Drugs
autologous adipose-derived stromal vascular fraction
03
Conditions
Rhizarthrosis
Beyond the preview
Go deeper on 2024-515317-18-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515317-18-00.